Fortrea Holdings FTRE
NASDAQ FTRE
$18.16 -0.46 (-2.47%)
As of: Sep 4, 2026 · 1:30 PM EDT

Fortrea Holdings (FTRE) Cash from Investing Activities (2022 - 2026)

Fortrea Holdings' (FTRE) quarterly Cash from Investing Activities came in at -$7.0 million in Q2 2026, up 6.67% YoY from -$6.6 million in Q2 2025, and up 12.5% on a QoQ basis from -$8.0 million in Q1 2026.

Analysis

Fortrea Holdings (FTRE) Cash from Investing Activities (2022 - 2026) Analysis & Trends

Fortrea Holdings (FTRE) has 5 years of Cash from Investing Activities data on file, last reported at -$7.0 million in Q2 2026.

  • Quarterly Cash from Investing Activities rose 6.67% year-over-year to -$7.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$9.2 million (down 330.0% YoY) and the FY2025 annual result came in at $14.4 million, down 94.28% from the prior year.
  • Cash from Investing Activities rose to -$7.0 million in Q2 2026, from -$8.0 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $265.4 million in Q2 2024 to a low of -$18.4 million in Q4 2022.
  • A 5-year average of $11.5 million and a median of -$7.8 million in 2025 frame the typical range for Cash from Investing Activities.
  • The widest YoY moves for Cash from Investing Activities: up 2953.76% in 2024, down 400.0% in 2024.
  • Tracing FTRE's Cash from Investing Activities over 5 years: stood at -$18.4 million in 2022, then jumped by 51.09% to -$9.0 million in 2023, then soared by 138.89% to $3.5 million in 2024, then sank by 314.29% to -$7.5 million in 2025, then advanced by 6.67% to -$7.0 million in 2026.
  • The last three Cash from Investing Activities figures came in at -$7.0 million (Q2 2026), -$8.0 million (Q1 2026), and -$7.5 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Vertex Pharmaceuticals 139.31 Bn 131.46 Bn 2.84 Bn -45.80 Mn
2 Regeneron Pharmaceuticals 85.65 Bn 77.66 Bn 3.93 Bn -92.70 Mn
3 Argenx Se 63.46 Bn 58.27 Bn 1.37 Bn -
4 Moderna 57.94 Bn 52.80 Bn 52.00 Mn 329.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn - -1.66 Bn
6 BeOne Medicines 39.96 Bn 34.86 Bn 1.53 Bn -49.35 Mn
7 Alnylam Pharmaceuticals 35.16 Bn 31.85 Bn 992.69 Mn -363.46 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn - -229.72 Mn
9 Insmed 27.32 Bn 26.16 Bn 358.27 Mn 24.51 Mn
10 Fortrea Holdings 1.72 Bn 1.55 Bn 139.20 Mn -7.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -7.00 Mn
Mar 31, 2026 -8.00 Mn
Dec 31, 2025 -7.50 Mn
Sep 30, 2025 13.30 Mn
Jun 30, 2025 -7.50 Mn
Mar 31, 2025 16.10 Mn
Dec 31, 2024 3.50 Mn
Sep 30, 2024 -8.10 Mn
Jun 30, 2024 265.40 Mn
Mar 31, 2024 -9.20 Mn
Dec 31, 2023 -9.00 Mn
Sep 30, 2023 2.70 Mn
Jun 30, 2023 -9.30 Mn
Mar 31, 2023 -16.20 Mn
Dec 31, 2022 -18.40 Mn
Sep 30, 2022 -16.90 Mn